Blog

Resolution of the Collegiate Board (RDC) 579/2021, issued by the National Health Surveillance Agency (ANVISA), establishes important norms regarding the...

RDC 850/2024 was published today, which amends RDC 497/2021 in its Article 8 with the inclusion of information that manufacturers...

Anvisa has recently announced an update to safety and performance requirements for medical devices, including in vitro diagnostic devices (IVDs),...

Only in public bids mapped by our bid tracking system did we find more than 45 million in sales for...

Recently, the National Health Surveillance Agency (Anvisa) issued an informative statement regarding the use of smartwatches for glucose monitoring. This...

1 – I have products registered in the name of my distributor or even in the name of acompany that...

In the current context of Brazilian public health, the effective detection and monitoring of notifiable diseases such as Dengue, HIV,...

Navigating regulatory complexities in Brazil is a challenge for many companies, especially those operating in the healthcare field. In this...

ANVISA’s Regulatory Agenda is a fundamental pillar for predictability and the evolution of the regulatory environment in Brazil. Its relevance...